| Health Care Technology Industry | Healthcare Sector | Dr. Jong-sik Chun CEO | KRX SM Exchange | - ISIN |
| KR Country | 122 Employees | - Last Dividend | - Last Split | - IPO Date |
CJ Bioscience, Inc., originally known as ChunLab, Inc., is a renowned entity committed to advancing microbiome research solutions. Based in Seoul, South Korea, the company extends its innovative services and products both domestically and internationally, catering to a diverse clientele that includes companies, hospitals, and individuals within the healthcare realm. Since its establishment in 2009, CJ Bioscience has been at the forefront of employing cutting-edge technology to explore microbiomes - the complex communities of microorganisms that reside in various environments. In December 2021, the organization underwent a rebranding, changing its name from ChunLab, Inc. to CJ Bioscience, Inc., signaling a new era of growth and expansion in microbiome research and applications.
A flagship cloud analysis platform designed by CJ Bioscience for the precise identification of microorganisms. TrueBac ID stands out for its ability to deliver fast, accurate, and comprehensive analysis, making it an indispensable tool for research and diagnostic processes involving microbial identification.
This public data and analytics portal provides a wealth of information on bacteria and archaea. Users can access detailed taxonomy, ecology, genomics, metagenomics, and microbiome data. EzBioCloud serves as a vital resource for researchers and professionals in the field, streamlining the process of gathering and analyzing microbiological data.
Smilegut is a specialized service aimed at monitoring the intestinal microbiome. It offers individuals insights into their gut health, enabling them to make informed decisions regarding their diet, lifestyle, and healthcare. This service underscores the importance of understanding the microbiome’s role in overall well-being and disease prevention.
A customized healthcare service, Smilebaby provides valuable information on infant growth based on the analysis of intestinal microflora. It supports parents and healthcare providers by offering insights into the optimal development of infants, emphasizing the critical impact of the microbiome from an early age.
This service delivers a comprehensive analysis of the composition and diversity of microbial communities. By profiling the taxonomic structure of microbiomes, CJ Bioscience aids in the understanding of microbial ecosystems and their implications for health, environment, and industrial applications.
Encompassing sequencing and interpretation, whole genome analysis facilitates the in-depth study of microbial genomes. This service is key to uncovering genetic information, elucidating microbial functions, and identifying novel features and potential biotechnological applications.
By comparing genomic sequences among different strains or species, this analysis highlights genetic similarities and differences. Such insights are invaluable for evolutionary studies, pathogen identification, and the development of targeted therapies and diagnostics.
This service examines the expression of genes within bacterial cells, offering insights into their functional activities under various conditions. Understanding bacterial gene expression is crucial for research into microbial physiology, pathogenesis, and the development of antimicrobial strategies.
CJ Bioscience provides detailed genomic reports for strains of bacteria and archaea that hold industrial significance. These reports offer comprehensive genetic insights, facilitating the optimization of strains for specific industrial processes and applications.